[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100635948":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":28,"responsibleParty":66,"collaborators":10,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":74,"eligibilityCriteria":75,"healthyVolunteers":70,"sex":76,"minAge":77,"maxAge":10,"enrollmentInfo":78,"targetDuration":10,"studyType":81,"phases":10,"briefSummary":82,"conditions":83,"keywords":87,"overallStatus":57,"whyStopped":10,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"Centre Hospitalier Intercommunal Creteil","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Suspected of outpatient urinary tract infection",null,"Inclusion of patients with outpatient urinary tract infection in emergency department",[13],"Other: Adaptation of antibiotics therapy for outpatient urinary infection following emergency care",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Adaptation of antibiotics therapy for outpatient urinary infection following emergency care","Re assessment of antibiotic therapy at 48 hours based on urine culture results : discontinuation or de-escalation to a narrower-spectrum agent",[9],[20,25],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Anna BELKACEM, MD","CONTACT","01 43 86 21 62","anna.belkacem@chiv.fr",{"name":26,"role":22,"phone":10,"phoneExt":10,"email":27},"Wissem TOUADI, Resident","wissemtouadi@gmail.com",[29,44,55],{"facility":30,"status":31,"city":32,"state":10,"zip":10,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"GHSIF","NOT_YET_RECRUITING","Melun","France","FR",{"type":36,"coordinates":37},"Point",[38,39],2.65356,48.5457,{"lat":39,"lon":38},[42],{"name":43,"role":22,"phone":10,"phoneExt":10,"email":10},"De Pontfarcy, MD",{"facility":45,"status":31,"city":46,"state":10,"zip":10,"country":33,"countryCode":34,"cosmosGeoPoint":47,"geoPoint":51,"contacts":52},"CH St denis","Saint-Denis",{"type":36,"coordinates":48},[49,50],2.35387,48.93564,{"lat":50,"lon":49},[53],{"name":54,"role":22,"phone":10,"phoneExt":10,"email":10},"SAYRE, MD",{"facility":56,"status":57,"city":58,"state":10,"zip":10,"country":33,"countryCode":34,"cosmosGeoPoint":59,"geoPoint":63,"contacts":64},"CHIV","RECRUITING","Villeneuve-Saint-Georges",{"type":36,"coordinates":60},[61,62],2.44925,48.73219,{"lat":62,"lon":61},[65],{"name":21,"role":22,"phone":10,"phoneExt":10,"email":10},{"type":67,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100635948","post-emergency-optimization-of-antibiotic-therapy-for-urinary-tract-infection-uti-100635948",false,"NCT07559318","Post-Emergency Optimization of Antibiotic Therapy for Urinary Tract Infection (UTI)","Post-Emergency Optimization of UTI Antibiotic Therapy: \"Fluoroquinolones and Third-Generation Cephalosporins Under the Spotlight\"","REVIU48","Inclusion Criteria:\n\n* Age 18 years or over\n* Patients presenting at emergency department, with symptoms suggestive of a urinary tract infection suitable for outpatient management (uncomplicated cystitis or cystitis at risk of complications, uncomplicated pyelonephritis or pyelonephritis at risk of complications, male urinary tract infection with or without fever) who have had a urine culture taken\n\nExclusion Criteria:\n\n* Refusal to participate in the study\n* Vulnerable person (person under guardianship or trusteeship, minor, person deprived of liberty, person unable to express their refusal)\n* Pregnant women\n* Severe urinary tract infection (sepsis, septic shock or requiring drainage, except for low urinary catheterisation)\n* Hospitalisation for a urinary tract infection or decompensation of another comorbidity\n* Suspected urinary tract infection without a urine culture having been performed","ALL","18 Years",{"count":79,"type":80},330,"ESTIMATED","OBSERVATIONAL","Prospective, multicenter, non-interventional study conducted over 6 months, including patients presenting to the emergency department with suspected urinary tract infection managed as outpatients and discharged with or without empiric antibiotic therapy.\n\nDischarge antibiotic prescriptions are reviewed, with subsequent reassessment and optimization of treatment based on urine culture and susceptibility results",[84,85,86],"Urinary Tract Infections","Antiobiotic Stewardship","Emerging Infectious Disease",[88,89,90,91,92],"Urinary tract infection","Urine culture and sensitivity tests","Antimicrobial stewarship","Side effect and adverse event of antibiotics","Fluoroquinolones and 3rd-generation cephalosporins","2026-06-10",{"date":95,"type":96},"2026-06-12","ACTUAL",{"date":98,"type":80},"2026-06-01",{"date":100,"type":80},"2027-01-01",{"name":5,"class":6},3]